0001567619-22-017414.txt : 20220914
0001567619-22-017414.hdr.sgml : 20220914
20220914161541
ACCESSION NUMBER: 0001567619-22-017414
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220912
FILED AS OF DATE: 20220914
DATE AS OF CHANGE: 20220914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Medpace Investors, LLC
CENTRAL INDEX KEY: 0001524599
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37856
FILM NUMBER: 221243159
BUSINESS ADDRESS:
STREET 1: 4620 WESLEY AVENUE
CITY: CINCINNATI
STATE: OH
ZIP: 45212
BUSINESS PHONE: 513-579-9911
MAIL ADDRESS:
STREET 1: 4620 WESLEY AVENUE
CITY: CINCINNATI
STATE: OH
ZIP: 45212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medpace Holdings, Inc.
CENTRAL INDEX KEY: 0001668397
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 320434904
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
BUSINESS PHONE: (513) 579-9911
MAIL ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
4
1
doc1.xml
FORM 4
X0306
4
2022-09-12
0
0001668397
Medpace Holdings, Inc.
MEDP
0001524599
Medpace Investors, LLC
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
CINCINNATI
OH
45227
0
0
1
0
Common Stock
2022-09-12
4
P
0
62515
167.58
A
5893172
D
Common Stock
2022-09-13
4
P
0
62516
157.12
A
5955688
D
The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2022, as amended on May 3, 2022 and August 15, 2022.
The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $163.95 to $168.93. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $153.65 to $163.66. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
/s/ Stephen P. Ewald, Authorized Signatory for Medpace Investors, LLC
2022-09-14